nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—Alzheimer's disease	0.566	0.779	CbGaD
Cysteamine—MPO—Alzheimer's disease	0.16	0.221	CbGaD
Cysteamine—NPY2R—forebrain—Alzheimer's disease	0.0101	0.147	CbGeAlD
Cysteamine—NPY2R—telencephalon—Alzheimer's disease	0.00928	0.135	CbGeAlD
Cysteamine—SST—blood vessel—Alzheimer's disease	0.00747	0.109	CbGeAlD
Cysteamine—NPY2R—nervous system—Alzheimer's disease	0.00548	0.0799	CbGeAlD
Cysteamine—NPY2R—central nervous system—Alzheimer's disease	0.00528	0.0769	CbGeAlD
Cysteamine—SST—embryo—Alzheimer's disease	0.00446	0.0649	CbGeAlD
Cysteamine—NPY2R—brain—Alzheimer's disease	0.00419	0.0611	CbGeAlD
Cysteamine—SST—forebrain—Alzheimer's disease	0.00394	0.0574	CbGeAlD
Cysteamine—SST—telencephalon—Alzheimer's disease	0.00362	0.0528	CbGeAlD
Cysteamine—Skin striae—Donepezil—Alzheimer's disease	0.00312	0.0279	CcSEcCtD
Cysteamine—MPO—blood vessel—Alzheimer's disease	0.00301	0.0439	CbGeAlD
Cysteamine—Leg pain—Galantamine—Alzheimer's disease	0.00277	0.0248	CcSEcCtD
Cysteamine—Breath odour—Rivastigmine—Alzheimer's disease	0.00241	0.0216	CcSEcCtD
Cysteamine—SST—nervous system—Alzheimer's disease	0.00214	0.0312	CbGeAlD
Cysteamine—SST—central nervous system—Alzheimer's disease	0.00206	0.03	CbGeAlD
Cysteamine—Cerebral ischaemia—Donepezil—Alzheimer's disease	0.00205	0.0184	CcSEcCtD
Cysteamine—SST—cerebellum—Alzheimer's disease	0.00201	0.0293	CbGeAlD
Cysteamine—Leg pain—Memantine—Alzheimer's disease	0.00195	0.0175	CcSEcCtD
Cysteamine—Leg pain—Rivastigmine—Alzheimer's disease	0.00191	0.0171	CcSEcCtD
Cysteamine—Appetite absent—Rivastigmine—Alzheimer's disease	0.00177	0.0159	CcSEcCtD
Cysteamine—SST—brain—Alzheimer's disease	0.00164	0.0238	CbGeAlD
Cysteamine—MPO—forebrain—Alzheimer's disease	0.00159	0.0231	CbGeAlD
Cysteamine—Encephalopathy—Memantine—Alzheimer's disease	0.0014	0.0126	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Galantamine—Alzheimer's disease	0.00128	0.0115	CcSEcCtD
Cysteamine—Nightmare—Galantamine—Alzheimer's disease	0.00123	0.0111	CcSEcCtD
Cysteamine—Hyperkinesia—Galantamine—Alzheimer's disease	0.00111	0.01	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Galantamine—Alzheimer's disease	0.00107	0.00957	CcSEcCtD
Cysteamine—Gastroenteritis—Galantamine—Alzheimer's disease	0.00105	0.00939	CcSEcCtD
Cysteamine—Bone disorder—Memantine—Alzheimer's disease	0.000996	0.00893	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Donepezil—Alzheimer's disease	0.000991	0.00889	CcSEcCtD
Cysteamine—Thinking abnormal—Memantine—Alzheimer's disease	0.000983	0.00881	CcSEcCtD
Cysteamine—Bone disorder—Rivastigmine—Alzheimer's disease	0.000974	0.00874	CcSEcCtD
Cysteamine—Lethargy—Galantamine—Alzheimer's disease	0.000947	0.00849	CcSEcCtD
Cysteamine—Pain in extremity—Galantamine—Alzheimer's disease	0.000928	0.00832	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Memantine—Alzheimer's disease	0.0009	0.00807	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Rivastigmine—Alzheimer's disease	0.00088	0.00789	CcSEcCtD
Cysteamine—Ataxia—Galantamine—Alzheimer's disease	0.000873	0.00783	CcSEcCtD
Cysteamine—Nightmare—Memantine—Alzheimer's disease	0.000869	0.00779	CcSEcCtD
Cysteamine—Dehydration—Galantamine—Alzheimer's disease	0.000863	0.00774	CcSEcCtD
Cysteamine—MPO—nervous system—Alzheimer's disease	0.000862	0.0126	CbGeAlD
Cysteamine—Nightmare—Rivastigmine—Alzheimer's disease	0.00085	0.00762	CcSEcCtD
Cysteamine—MPO—central nervous system—Alzheimer's disease	0.000829	0.0121	CbGeAlD
Cysteamine—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.000827	0.00742	CcSEcCtD
Cysteamine—Gastroenteritis—Donepezil—Alzheimer's disease	0.000811	0.00728	CcSEcCtD
Cysteamine—Hyperkinesia—Memantine—Alzheimer's disease	0.000785	0.00704	CcSEcCtD
Cysteamine—Mental disability—Memantine—Alzheimer's disease	0.000781	0.007	CcSEcCtD
Cysteamine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000767	0.00688	CcSEcCtD
Cysteamine—Mental disability—Rivastigmine—Alzheimer's disease	0.000764	0.00685	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.000751	0.00673	CcSEcCtD
Cysteamine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.000747	0.0067	CcSEcCtD
Cysteamine—Gastroenteritis—Memantine—Alzheimer's disease	0.000737	0.00661	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.000734	0.00659	CcSEcCtD
Cysteamine—Eye pain—Memantine—Alzheimer's disease	0.000723	0.00649	CcSEcCtD
Cysteamine—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.000721	0.00646	CcSEcCtD
Cysteamine—Affect lability—Donepezil—Alzheimer's disease	0.000708	0.00635	CcSEcCtD
Cysteamine—Eye pain—Rivastigmine—Alzheimer's disease	0.000708	0.00635	CcSEcCtD
Cysteamine—Renal failure—Galantamine—Alzheimer's disease	0.000703	0.00631	CcSEcCtD
Cysteamine—Mood swings—Donepezil—Alzheimer's disease	0.000681	0.00611	CcSEcCtD
Cysteamine—Ataxia—Donepezil—Alzheimer's disease	0.000676	0.00607	CcSEcCtD
Cysteamine—Dehydration—Donepezil—Alzheimer's disease	0.000669	0.006	CcSEcCtD
Cysteamine—Lethargy—Memantine—Alzheimer's disease	0.000666	0.00598	CcSEcCtD
Cysteamine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000664	0.00596	CcSEcCtD
Cysteamine—MPO—brain—Alzheimer's disease	0.000659	0.0096	CbGeAlD
Cysteamine—Pain in extremity—Memantine—Alzheimer's disease	0.000653	0.00586	CcSEcCtD
Cysteamine—Affect lability—Memantine—Alzheimer's disease	0.000643	0.00576	CcSEcCtD
Cysteamine—Pain in extremity—Rivastigmine—Alzheimer's disease	0.000639	0.00573	CcSEcCtD
Cysteamine—Hallucination—Galantamine—Alzheimer's disease	0.000639	0.00573	CcSEcCtD
Cysteamine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000634	0.00569	CcSEcCtD
Cysteamine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000631	0.00566	CcSEcCtD
Cysteamine—Urethral disorder—Galantamine—Alzheimer's disease	0.000629	0.00564	CcSEcCtD
Cysteamine—Affect lability—Rivastigmine—Alzheimer's disease	0.000629	0.00564	CcSEcCtD
Cysteamine—Mood swings—Memantine—Alzheimer's disease	0.000619	0.00555	CcSEcCtD
Cysteamine—Ataxia—Memantine—Alzheimer's disease	0.000614	0.00551	CcSEcCtD
Cysteamine—Dehydration—Memantine—Alzheimer's disease	0.000607	0.00545	CcSEcCtD
Cysteamine—Mood swings—Rivastigmine—Alzheimer's disease	0.000605	0.00543	CcSEcCtD
Cysteamine—Liver function test abnormal—Memantine—Alzheimer's disease	0.000603	0.00541	CcSEcCtD
Cysteamine—Ataxia—Rivastigmine—Alzheimer's disease	0.000601	0.00539	CcSEcCtD
Cysteamine—Dehydration—Rivastigmine—Alzheimer's disease	0.000594	0.00533	CcSEcCtD
Cysteamine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00059	0.00529	CcSEcCtD
Cysteamine—Immune system disorder—Galantamine—Alzheimer's disease	0.00058	0.0052	CcSEcCtD
Cysteamine—Mental disorder—Galantamine—Alzheimer's disease	0.000562	0.00504	CcSEcCtD
Cysteamine—Malnutrition—Galantamine—Alzheimer's disease	0.000559	0.00501	CcSEcCtD
Cysteamine—Tension—Galantamine—Alzheimer's disease	0.000548	0.00492	CcSEcCtD
Cysteamine—Renal failure—Donepezil—Alzheimer's disease	0.000545	0.00489	CcSEcCtD
Cysteamine—Nervousness—Galantamine—Alzheimer's disease	0.000543	0.00487	CcSEcCtD
Cysteamine—Tremor—Galantamine—Alzheimer's disease	0.000524	0.0047	CcSEcCtD
Cysteamine—Anaemia—Galantamine—Alzheimer's disease	0.000517	0.00463	CcSEcCtD
Cysteamine—Agitation—Galantamine—Alzheimer's disease	0.000514	0.00461	CcSEcCtD
Cysteamine—Hallucination—Donepezil—Alzheimer's disease	0.000495	0.00444	CcSEcCtD
Cysteamine—Renal failure—Memantine—Alzheimer's disease	0.000495	0.00444	CcSEcCtD
Cysteamine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000491	0.00441	CcSEcCtD
Cysteamine—Urethral disorder—Donepezil—Alzheimer's disease	0.000488	0.00437	CcSEcCtD
Cysteamine—Convulsion—Galantamine—Alzheimer's disease	0.000484	0.00434	CcSEcCtD
Cysteamine—Renal failure—Rivastigmine—Alzheimer's disease	0.000484	0.00434	CcSEcCtD
Cysteamine—Hypertension—Galantamine—Alzheimer's disease	0.000482	0.00433	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000472	0.00424	CcSEcCtD
Cysteamine—Discomfort—Galantamine—Alzheimer's disease	0.00047	0.00422	CcSEcCtD
Cysteamine—Confusional state—Galantamine—Alzheimer's disease	0.00046	0.00412	CcSEcCtD
Cysteamine—Hallucination—Memantine—Alzheimer's disease	0.000449	0.00403	CcSEcCtD
Cysteamine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000447	0.00401	CcSEcCtD
Cysteamine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000446	0.004	CcSEcCtD
Cysteamine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000444	0.00398	CcSEcCtD
Cysteamine—Skin disorder—Galantamine—Alzheimer's disease	0.000443	0.00397	CcSEcCtD
Cysteamine—Urethral disorder—Memantine—Alzheimer's disease	0.000443	0.00397	CcSEcCtD
Cysteamine—Hallucination—Rivastigmine—Alzheimer's disease	0.00044	0.00394	CcSEcCtD
Cysteamine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000436	0.00391	CcSEcCtD
Cysteamine—Mental disorder—Donepezil—Alzheimer's disease	0.000436	0.00391	CcSEcCtD
Cysteamine—Anorexia—Galantamine—Alzheimer's disease	0.000435	0.0039	CcSEcCtD
Cysteamine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000434	0.0039	CcSEcCtD
Cysteamine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000433	0.00389	CcSEcCtD
Cysteamine—Malnutrition—Donepezil—Alzheimer's disease	0.000433	0.00388	CcSEcCtD
Cysteamine—Erythema—Donepezil—Alzheimer's disease	0.000433	0.00388	CcSEcCtD
Cysteamine—Tension—Donepezil—Alzheimer's disease	0.000425	0.00381	CcSEcCtD
Cysteamine—Nervousness—Donepezil—Alzheimer's disease	0.000421	0.00377	CcSEcCtD
Cysteamine—Immune system disorder—Memantine—Alzheimer's disease	0.000408	0.00366	CcSEcCtD
Cysteamine—Tremor—Donepezil—Alzheimer's disease	0.000406	0.00364	CcSEcCtD
Cysteamine—Somnolence—Galantamine—Alzheimer's disease	0.000405	0.00364	CcSEcCtD
Cysteamine—Dyspepsia—Galantamine—Alzheimer's disease	0.000401	0.0036	CcSEcCtD
Cysteamine—Anaemia—Donepezil—Alzheimer's disease	0.0004	0.00359	CcSEcCtD
Cysteamine—Agitation—Donepezil—Alzheimer's disease	0.000398	0.00357	CcSEcCtD
Cysteamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000396	0.00356	CcSEcCtD
Cysteamine—Mental disorder—Memantine—Alzheimer's disease	0.000396	0.00355	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000394	0.00353	CcSEcCtD
Cysteamine—Malnutrition—Memantine—Alzheimer's disease	0.000393	0.00353	CcSEcCtD
Cysteamine—Fatigue—Galantamine—Alzheimer's disease	0.000393	0.00353	CcSEcCtD
Cysteamine—Constipation—Galantamine—Alzheimer's disease	0.00039	0.0035	CcSEcCtD
Cysteamine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000387	0.00347	CcSEcCtD
Cysteamine—Tension—Memantine—Alzheimer's disease	0.000386	0.00346	CcSEcCtD
Cysteamine—Erythema—Rivastigmine—Alzheimer's disease	0.000385	0.00345	CcSEcCtD
Cysteamine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000385	0.00345	CcSEcCtD
Cysteamine—Nervousness—Memantine—Alzheimer's disease	0.000382	0.00343	CcSEcCtD
Cysteamine—Tension—Rivastigmine—Alzheimer's disease	0.000377	0.00339	CcSEcCtD
Cysteamine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000376	0.00337	CcSEcCtD
Cysteamine—Convulsion—Donepezil—Alzheimer's disease	0.000375	0.00337	CcSEcCtD
Cysteamine—Hypertension—Donepezil—Alzheimer's disease	0.000374	0.00335	CcSEcCtD
Cysteamine—Nervousness—Rivastigmine—Alzheimer's disease	0.000374	0.00335	CcSEcCtD
Cysteamine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000373	0.00335	CcSEcCtD
Cysteamine—Tremor—Memantine—Alzheimer's disease	0.000368	0.0033	CcSEcCtD
Cysteamine—Discomfort—Donepezil—Alzheimer's disease	0.000364	0.00327	CcSEcCtD
Cysteamine—Anaemia—Memantine—Alzheimer's disease	0.000363	0.00326	CcSEcCtD
Cysteamine—Agitation—Memantine—Alzheimer's disease	0.000361	0.00324	CcSEcCtD
Cysteamine—Abdominal pain—Galantamine—Alzheimer's disease	0.000361	0.00323	CcSEcCtD
Cysteamine—Body temperature increased—Galantamine—Alzheimer's disease	0.000361	0.00323	CcSEcCtD
Cysteamine—Tremor—Rivastigmine—Alzheimer's disease	0.00036	0.00323	CcSEcCtD
Cysteamine—Confusional state—Donepezil—Alzheimer's disease	0.000356	0.0032	CcSEcCtD
Cysteamine—Anaemia—Rivastigmine—Alzheimer's disease	0.000356	0.00319	CcSEcCtD
Cysteamine—Agitation—Rivastigmine—Alzheimer's disease	0.000354	0.00317	CcSEcCtD
Cysteamine—Leukopenia—Memantine—Alzheimer's disease	0.000352	0.00316	CcSEcCtD
Cysteamine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000347	0.00311	CcSEcCtD
Cysteamine—Convulsion—Memantine—Alzheimer's disease	0.000341	0.00306	CcSEcCtD
Cysteamine—Hypertension—Memantine—Alzheimer's disease	0.000339	0.00305	CcSEcCtD
Cysteamine—Anorexia—Donepezil—Alzheimer's disease	0.000337	0.00302	CcSEcCtD
Cysteamine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000336	0.00301	CcSEcCtD
Cysteamine—Convulsion—Rivastigmine—Alzheimer's disease	0.000333	0.00299	CcSEcCtD
Cysteamine—Hypertension—Rivastigmine—Alzheimer's disease	0.000332	0.00298	CcSEcCtD
Cysteamine—Discomfort—Memantine—Alzheimer's disease	0.000331	0.00297	CcSEcCtD
Cysteamine—Asthenia—Galantamine—Alzheimer's disease	0.000327	0.00294	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000325	0.00292	CcSEcCtD
Cysteamine—Confusional state—Memantine—Alzheimer's disease	0.000324	0.0029	CcSEcCtD
Cysteamine—Discomfort—Rivastigmine—Alzheimer's disease	0.000324	0.0029	CcSEcCtD
Cysteamine—Confusional state—Rivastigmine—Alzheimer's disease	0.000317	0.00284	CcSEcCtD
Cysteamine—Nervous system disorder—Memantine—Alzheimer's disease	0.000315	0.00282	CcSEcCtD
Cysteamine—Somnolence—Donepezil—Alzheimer's disease	0.000314	0.00282	CcSEcCtD
Cysteamine—Diarrhoea—Galantamine—Alzheimer's disease	0.000312	0.0028	CcSEcCtD
Cysteamine—Skin disorder—Memantine—Alzheimer's disease	0.000312	0.0028	CcSEcCtD
Cysteamine—Dyspepsia—Donepezil—Alzheimer's disease	0.000311	0.00279	CcSEcCtD
Cysteamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000308	0.00276	CcSEcCtD
Cysteamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000307	0.00276	CcSEcCtD
Cysteamine—Anorexia—Memantine—Alzheimer's disease	0.000306	0.00274	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000305	0.00274	CcSEcCtD
Cysteamine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000305	0.00274	CcSEcCtD
Cysteamine—Fatigue—Donepezil—Alzheimer's disease	0.000305	0.00273	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—NPY—Alzheimer's disease	0.000305	0.00327	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—IAPP—Alzheimer's disease	0.000303	0.00325	CbGpPWpGaD
Cysteamine—Constipation—Donepezil—Alzheimer's disease	0.000302	0.00271	CcSEcCtD
Cysteamine—Dizziness—Galantamine—Alzheimer's disease	0.000302	0.00271	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.0003	0.00322	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PYY—Alzheimer's disease	0.000299	0.00322	CbGpPWpGaD
Cysteamine—Anorexia—Rivastigmine—Alzheimer's disease	0.000299	0.00268	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—Alzheimer's disease	0.000299	0.00321	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.000295	0.00317	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CRH—Alzheimer's disease	0.000294	0.00316	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—LEP—Alzheimer's disease	0.000292	0.00313	CbGpPWpGaD
Cysteamine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000291	0.00261	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—NPS—Alzheimer's disease	0.000291	0.00312	CbGpPWpGaD
Cysteamine—Vomiting—Galantamine—Alzheimer's disease	0.00029	0.0026	CcSEcCtD
Cysteamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000289	0.00259	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.000288	0.00309	CbGpPWpGaD
Cysteamine—Rash—Galantamine—Alzheimer's disease	0.000288	0.00258	CcSEcCtD
Cysteamine—Dermatitis—Galantamine—Alzheimer's disease	0.000287	0.00258	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PYY—Alzheimer's disease	0.000287	0.00308	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000286	0.00307	CbGpPWpGaD
Cysteamine—Headache—Galantamine—Alzheimer's disease	0.000286	0.00256	CcSEcCtD
Cysteamine—Somnolence—Memantine—Alzheimer's disease	0.000285	0.00256	CcSEcCtD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.000283	0.00304	CbGpPWpGaD
Cysteamine—Dyspepsia—Memantine—Alzheimer's disease	0.000282	0.00253	CcSEcCtD
Cysteamine—Urticaria—Donepezil—Alzheimer's disease	0.000281	0.00252	CcSEcCtD
Cysteamine—Body temperature increased—Donepezil—Alzheimer's disease	0.000279	0.00251	CcSEcCtD
Cysteamine—Abdominal pain—Donepezil—Alzheimer's disease	0.000279	0.00251	CcSEcCtD
Cysteamine—Somnolence—Rivastigmine—Alzheimer's disease	0.000279	0.0025	CcSEcCtD
Cysteamine—Decreased appetite—Memantine—Alzheimer's disease	0.000279	0.0025	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—NPS—Alzheimer's disease	0.000279	0.00299	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—F2—Alzheimer's disease	0.000278	0.00299	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000277	0.00249	CcSEcCtD
Cysteamine—Fatigue—Memantine—Alzheimer's disease	0.000277	0.00248	CcSEcCtD
Cysteamine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000276	0.00248	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000275	0.00296	CbGpPWpGaD
Cysteamine—Constipation—Memantine—Alzheimer's disease	0.000274	0.00246	CcSEcCtD
Cysteamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000273	0.00245	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000272	0.00292	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000271	0.00243	CcSEcCtD
Cysteamine—Nausea—Galantamine—Alzheimer's disease	0.000271	0.00243	CcSEcCtD
Cysteamine—Fatigue—Rivastigmine—Alzheimer's disease	0.000271	0.00243	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—APP—Alzheimer's disease	0.00027	0.0029	CbGpPWpGaD
Cysteamine—Constipation—Rivastigmine—Alzheimer's disease	0.000268	0.00241	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000267	0.00287	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—SST—Alzheimer's disease	0.000266	0.00285	CbGpPWpGaD
Cysteamine—Feeling abnormal—Memantine—Alzheimer's disease	0.000264	0.00237	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000264	0.00283	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000262	0.00282	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000262	0.00235	CcSEcCtD
Cysteamine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00026	0.00234	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CDK5—Alzheimer's disease	0.00026	0.00279	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—APP—Alzheimer's disease	0.000259	0.00278	CbGpPWpGaD
Cysteamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000259	0.00232	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000257	0.00276	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000257	0.0023	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000256	0.00275	CbGpPWpGaD
Cysteamine—Urticaria—Memantine—Alzheimer's disease	0.000255	0.00229	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000254	0.00273	CbGpPWpGaD
Cysteamine—Body temperature increased—Memantine—Alzheimer's disease	0.000254	0.00228	CcSEcCtD
Cysteamine—Abdominal pain—Memantine—Alzheimer's disease	0.000254	0.00228	CcSEcCtD
Cysteamine—Asthenia—Donepezil—Alzheimer's disease	0.000254	0.00227	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000253	0.00271	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—INS—Alzheimer's disease	0.000252	0.00271	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000252	0.00271	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—CREB1—Alzheimer's disease	0.00025	0.00269	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR6—Alzheimer's disease	0.00025	0.00268	CbGpPWpGaD
Cysteamine—Urticaria—Rivastigmine—Alzheimer's disease	0.000249	0.00224	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CDK5—Alzheimer's disease	0.000249	0.00267	CbGpPWpGaD
Cysteamine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000248	0.00223	CcSEcCtD
Cysteamine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000248	0.00223	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—CCL2—Alzheimer's disease	0.000248	0.00266	CbGpPWpGaD
Cysteamine—Diarrhoea—Donepezil—Alzheimer's disease	0.000242	0.00217	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—HTR6—Alzheimer's disease	0.00024	0.00257	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000237	0.00255	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000237	0.00255	CbGpPWpGaD
Cysteamine—Hypersensitivity—Memantine—Alzheimer's disease	0.000236	0.00212	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000235	0.00252	CbGpPWpGaD
Cysteamine—Dizziness—Donepezil—Alzheimer's disease	0.000234	0.0021	CcSEcCtD
Cysteamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000231	0.00207	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—Alzheimer's disease	0.000231	0.00248	CbGpPWpGaD
Cysteamine—Asthenia—Memantine—Alzheimer's disease	0.00023	0.00207	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00023	0.00247	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GAL—Alzheimer's disease	0.000229	0.00246	CbGpPWpGaD
Cysteamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000225	0.00202	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000225	0.00242	CbGpPWpGaD
Cysteamine—Vomiting—Donepezil—Alzheimer's disease	0.000225	0.00202	CcSEcCtD
Cysteamine—Rash—Donepezil—Alzheimer's disease	0.000223	0.002	CcSEcCtD
Cysteamine—Dermatitis—Donepezil—Alzheimer's disease	0.000223	0.002	CcSEcCtD
Cysteamine—Headache—Donepezil—Alzheimer's disease	0.000221	0.00199	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000221	0.00238	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00022	0.00236	CbGpPWpGaD
Cysteamine—Diarrhoea—Memantine—Alzheimer's disease	0.00022	0.00197	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—GAL—Alzheimer's disease	0.000219	0.00235	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—Alzheimer's disease	0.000217	0.00233	CbGpPWpGaD
Cysteamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000215	0.00193	CcSEcCtD
Cysteamine—Dizziness—Memantine—Alzheimer's disease	0.000212	0.0019	CcSEcCtD
Cysteamine—Nausea—Donepezil—Alzheimer's disease	0.00021	0.00188	CcSEcCtD
Cysteamine—Dizziness—Rivastigmine—Alzheimer's disease	0.000208	0.00186	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—GAL—Alzheimer's disease	0.000208	0.00223	CbGpPWpGaD
Cysteamine—Vomiting—Memantine—Alzheimer's disease	0.000204	0.00183	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TTR—Alzheimer's disease	0.000202	0.00217	CbGpPWpGaD
Cysteamine—Rash—Memantine—Alzheimer's disease	0.000202	0.00182	CcSEcCtD
Cysteamine—Dermatitis—Memantine—Alzheimer's disease	0.000202	0.00181	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000201	0.00216	CbGpPWpGaD
Cysteamine—Headache—Memantine—Alzheimer's disease	0.000201	0.0018	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000201	0.00216	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—INS—Alzheimer's disease	0.0002	0.00215	CbGpPWpGaD
Cysteamine—Vomiting—Rivastigmine—Alzheimer's disease	0.0002	0.00179	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—GAL—Alzheimer's disease	0.000199	0.00214	CbGpPWpGaD
Cysteamine—Rash—Rivastigmine—Alzheimer's disease	0.000198	0.00178	CcSEcCtD
Cysteamine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000198	0.00177	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000197	0.00212	CbGpPWpGaD
Cysteamine—Headache—Rivastigmine—Alzheimer's disease	0.000197	0.00176	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TTR—Alzheimer's disease	0.000194	0.00208	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000193	0.00207	CbGpPWpGaD
Cysteamine—Nausea—Memantine—Alzheimer's disease	0.000191	0.00171	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL1B—Alzheimer's disease	0.000188	0.00202	CbGpPWpGaD
Cysteamine—Nausea—Rivastigmine—Alzheimer's disease	0.000186	0.00167	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—NPY—Alzheimer's disease	0.00018	0.00193	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000179	0.00193	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR5—Alzheimer's disease	0.000179	0.00192	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000178	0.00192	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PYY—Alzheimer's disease	0.000177	0.0019	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.000176	0.00189	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—Alzheimer's disease	0.000175	0.00188	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000175	0.00188	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CRH—Alzheimer's disease	0.000173	0.00186	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000172	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—NPY—Alzheimer's disease	0.000172	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000172	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR5—Alzheimer's disease	0.000171	0.00184	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000171	0.00184	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.00017	0.00183	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PYY—Alzheimer's disease	0.00017	0.00182	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—Alzheimer's disease	0.000168	0.0018	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000168	0.0018	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—Alzheimer's disease	0.000167	0.00179	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CRH—Alzheimer's disease	0.000166	0.00178	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—NPS—Alzheimer's disease	0.000164	0.00176	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NPY—Alzheimer's disease	0.000163	0.00175	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IAPP—Alzheimer's disease	0.000162	0.00174	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	0.000161	0.00173	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—NPS—Alzheimer's disease	0.000157	0.00169	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CRH—Alzheimer's disease	0.000157	0.00169	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000157	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NPY—Alzheimer's disease	0.000156	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IAPP—Alzheimer's disease	0.000155	0.00167	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDK5—Alzheimer's disease	0.000153	0.00165	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—F2—Alzheimer's disease	0.000153	0.00165	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—APP—Alzheimer's disease	0.000153	0.00164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CRH—Alzheimer's disease	0.000151	0.00162	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—SST—Alzheimer's disease	0.00015	0.00161	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GAB2—Alzheimer's disease	0.00015	0.00161	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000149	0.00161	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NPS—Alzheimer's disease	0.000149	0.0016	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000148	0.00159	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR6—Alzheimer's disease	0.000148	0.00159	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDK5—Alzheimer's disease	0.000147	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—F2—Alzheimer's disease	0.000147	0.00158	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—APP—Alzheimer's disease	0.000146	0.00157	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000144	0.00155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NPS—Alzheimer's disease	0.000143	0.00154	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GAB2—Alzheimer's disease	0.000142	0.00153	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000142	0.00153	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR6—Alzheimer's disease	0.000142	0.00152	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000139	0.00149	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—APP—Alzheimer's disease	0.000139	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000138	0.00148	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL2—Alzheimer's disease	0.000137	0.00147	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—Alzheimer's disease	0.000137	0.00147	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GAB2—Alzheimer's disease	0.000136	0.00147	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—SST—Alzheimer's disease	0.000136	0.00147	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.000135	0.00145	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PSENEN—Alzheimer's disease	0.000134	0.00144	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—APP—Alzheimer's disease	0.000133	0.00143	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APH1A—Alzheimer's disease	0.000132	0.00142	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL2—Alzheimer's disease	0.000131	0.00141	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000131	0.00141	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NCSTN—Alzheimer's disease	0.000129	0.00138	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PSENEN—Alzheimer's disease	0.000129	0.00138	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APH1A—Alzheimer's disease	0.000127	0.00136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LRP1—Alzheimer's disease	0.000126	0.00135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000125	0.00135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NCSTN—Alzheimer's disease	0.000123	0.00133	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GFAP—Alzheimer's disease	0.000123	0.00132	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GAL—Alzheimer's disease	0.000123	0.00132	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—Alzheimer's disease	0.00012	0.00129	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LRP1—Alzheimer's disease	0.00012	0.00129	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—Alzheimer's disease	0.000119	0.00128	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GFAP—Alzheimer's disease	0.000118	0.00126	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GAL—Alzheimer's disease	0.000118	0.00126	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—Alzheimer's disease	0.00011	0.00118	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—Alzheimer's disease	0.000109	0.00117	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—Alzheimer's disease	0.000108	0.00117	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—A2M—Alzheimer's disease	0.000108	0.00116	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000107	0.00114	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PSEN2—Alzheimer's disease	0.000105	0.00112	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—A2M—Alzheimer's disease	0.000104	0.00111	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000102	0.0011	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000101	0.00108	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PSEN2—Alzheimer's disease	0.0001	0.00108	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.88e-05	0.00106	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—Alzheimer's disease	9.68e-05	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCG—Alzheimer's disease	9.67e-05	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NPY—Alzheimer's disease	9.63e-05	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IAPP—Alzheimer's disease	9.57e-05	0.00103	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.47e-05	0.00102	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CRH—Alzheimer's disease	9.29e-05	0.000998	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCG—Alzheimer's disease	9.27e-05	0.000996	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NPY—Alzheimer's disease	9.23e-05	0.000992	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IAPP—Alzheimer's disease	9.18e-05	0.000986	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR5—Alzheimer's disease	9.17e-05	0.000985	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR2A—Alzheimer's disease	8.97e-05	0.000964	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CRH—Alzheimer's disease	8.91e-05	0.000957	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NPS—Alzheimer's disease	8.81e-05	0.000946	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—Alzheimer's disease	8.79e-05	0.000944	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP3CA—Alzheimer's disease	8.76e-05	0.000942	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—Alzheimer's disease	8.75e-05	0.00094	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—F2—Alzheimer's disease	8.66e-05	0.00093	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTK2B—Alzheimer's disease	8.64e-05	0.000928	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2A—Alzheimer's disease	8.6e-05	0.000924	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NPS—Alzheimer's disease	8.44e-05	0.000907	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GAB2—Alzheimer's disease	8.4e-05	0.000903	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NTRK2—Alzheimer's disease	8.4e-05	0.000903	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PPP3CA—Alzheimer's disease	8.4e-05	0.000903	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CALM1—Alzheimer's disease	8.37e-05	0.000899	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GSK3A—Alzheimer's disease	8.33e-05	0.000895	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—F2—Alzheimer's disease	8.3e-05	0.000892	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTK2B—Alzheimer's disease	8.28e-05	0.00089	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APP—Alzheimer's disease	8.19e-05	0.00088	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SST—Alzheimer's disease	8.06e-05	0.000865	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NTRK2—Alzheimer's disease	8.06e-05	0.000865	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GAB2—Alzheimer's disease	8.06e-05	0.000865	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CALM1—Alzheimer's disease	8.02e-05	0.000862	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GSK3A—Alzheimer's disease	7.99e-05	0.000858	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—F2—Alzheimer's disease	7.86e-05	0.000845	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APP—Alzheimer's disease	7.85e-05	0.000843	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLCB1—Alzheimer's disease	7.73e-05	0.00083	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—F2—Alzheimer's disease	7.54e-05	0.00081	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLCB1—Alzheimer's disease	7.41e-05	0.000796	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGFR—Alzheimer's disease	7.21e-05	0.000775	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CREB1—Alzheimer's disease	7.16e-05	0.00077	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADAM10—Alzheimer's disease	7.04e-05	0.000757	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL2—Alzheimer's disease	7.01e-05	0.000753	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGFR—Alzheimer's disease	6.91e-05	0.000743	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CREB1—Alzheimer's disease	6.87e-05	0.000738	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADAM10—Alzheimer's disease	6.75e-05	0.000725	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—Alzheimer's disease	6.72e-05	0.000722	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—S100B—Alzheimer's disease	6.66e-05	0.000715	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—S100B—Alzheimer's disease	6.38e-05	0.000686	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF2—Alzheimer's disease	6.34e-05	0.000681	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1R—Alzheimer's disease	6.13e-05	0.000659	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF2—Alzheimer's disease	6.08e-05	0.000653	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LPL—Alzheimer's disease	5.88e-05	0.000631	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—Alzheimer's disease	5.88e-05	0.000631	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MEF2C—Alzheimer's disease	5.82e-05	0.000626	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCG—Alzheimer's disease	5.71e-05	0.000614	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LPL—Alzheimer's disease	5.63e-05	0.000605	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MEF2C—Alzheimer's disease	5.58e-05	0.0006	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGF—Alzheimer's disease	5.57e-05	0.000598	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCG—Alzheimer's disease	5.48e-05	0.000589	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR5—Alzheimer's disease	5.41e-05	0.000582	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGF—Alzheimer's disease	5.34e-05	0.000573	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2A—Alzheimer's disease	5.3e-05	0.000569	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR5—Alzheimer's disease	5.19e-05	0.000558	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR2A—Alzheimer's disease	5.08e-05	0.000546	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CALM1—Alzheimer's disease	4.94e-05	0.000531	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—Alzheimer's disease	4.93e-05	0.000529	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LEP—Alzheimer's disease	4.93e-05	0.000529	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CAV1—Alzheimer's disease	4.88e-05	0.000524	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CALM1—Alzheimer's disease	4.74e-05	0.000509	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—Alzheimer's disease	4.72e-05	0.000507	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOE—Alzheimer's disease	4.72e-05	0.000507	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—Alzheimer's disease	4.7e-05	0.000505	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—Alzheimer's disease	4.68e-05	0.000503	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—F2—Alzheimer's disease	4.65e-05	0.000499	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOTCH1—Alzheimer's disease	4.55e-05	0.000488	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ESR1—Alzheimer's disease	4.51e-05	0.000484	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—F2—Alzheimer's disease	4.45e-05	0.000479	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH1—Alzheimer's disease	4.36e-05	0.000468	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GSK3B—Alzheimer's disease	4.27e-05	0.000458	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREB1—Alzheimer's disease	4.23e-05	0.000455	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INS—Alzheimer's disease	4.21e-05	0.000452	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—Alzheimer's disease	4.14e-05	0.000445	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GSK3B—Alzheimer's disease	4.09e-05	0.000439	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—Alzheimer's disease	4.07e-05	0.000437	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CREB1—Alzheimer's disease	4.06e-05	0.000436	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INS—Alzheimer's disease	4.03e-05	0.000433	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL2—Alzheimer's disease	3.97e-05	0.000426	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—Alzheimer's disease	3.9e-05	0.000419	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—Alzheimer's disease	3.69e-05	0.000396	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—Alzheimer's disease	3.54e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—Alzheimer's disease	3.16e-05	0.00034	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—Alzheimer's disease	3.13e-05	0.000337	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—Alzheimer's disease	3.11e-05	0.000334	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—Alzheimer's disease	3.03e-05	0.000326	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—Alzheimer's disease	3e-05	0.000323	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—Alzheimer's disease	2.98e-05	0.000321	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—Alzheimer's disease	2.88e-05	0.000309	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—Alzheimer's disease	2.87e-05	0.000309	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—Alzheimer's disease	2.76e-05	0.000297	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—Alzheimer's disease	2.75e-05	0.000296	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—Alzheimer's disease	2.66e-05	0.000286	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—Alzheimer's disease	2.55e-05	0.000274	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—Alzheimer's disease	2.44e-05	0.000262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—Alzheimer's disease	2.34e-05	0.000251	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—Alzheimer's disease	2.01e-05	0.000216	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—Alzheimer's disease	1.93e-05	0.000207	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—Alzheimer's disease	1.84e-05	0.000198	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—Alzheimer's disease	1.76e-05	0.000189	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—Alzheimer's disease	1.7e-05	0.000182	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—Alzheimer's disease	1.63e-05	0.000175	CbGpPWpGaD
